The prime culprit for yesterday’s 9.8% drop in Merck was what seemed to be a rather slight slip in Gardasil revenue – Merck’s HPV vaccine – which came in about $20 million below consensus. At $113 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback